What is the price-to-earnings ratio of CardieX?
The price-earnings ratio of CardieX is currently 1.16.
CardieX P/S 2024
CardieX P/S
1.16
Ticker
CDX.AX
ISIN
AU0000015729
WKN
A2JN9Z
As of Nov 8, 2024, CardieX's P/S ratio stood at 1.16, a -80.6% change from the 5.98 P/S ratio recorded in the previous year.
The CardieX P/S history
CardieX Aktienanalyse
What does CardieX do?
Cardiex Ltd is an Australian medical technology company specializing in the development and marketing of cardiovascular monitoring systems and diagnostic tools. The company was founded in 1996 and is based in Melbourne. Cardiex's history begins with the development of SphygmoCor technology in collaboration with researchers from Monash University. This technology allows for non-invasive measurement of pulse and blood pressure waves in the arteries, providing information about the condition of the cardiovascular system. Cardiex's first product was the SphygmoCor Analyzer, which was launched in 1999. Over time, additional products and technologies have been developed to meet the growing demand for cardiovascular monitoring and diagnostics. Cardiex's business model is based on the development and marketing of innovative medical technologies for the international market. The company works closely with clinics, research institutions, and medical device manufacturers to develop products that meet the needs of the healthcare sector. Cardiex has a comprehensive network of sales and marketing partners in over 40 countries worldwide. Cardiex operates in several divisions, including: - Diagnostic Systems: This division includes products such as the SphygmoCor Analyzer, which assesses arterial health, and the Arterial Stiffness Scanner, which enables early detection of cardiovascular risk factors. - Telemedicine: Cardiex offers a telehealth platform that allows clinics and medical personnel to monitor and analyze patient data in real-time. The platform can be used for remote patient monitoring, early detection of complications, and treatment optimization. - Research and Development: Cardiex collaborates closely with researchers and medical institutions to develop new technologies for cardiovascular monitoring and diagnostics. The company invests heavily in research and development to maintain a leading role in the field of medical technology. An important aspect of Cardiex's business model is its partnership with other companies. The company works closely with device manufacturers, software developers, and other service providers to integrate its technologies and products, offering complete solutions for the healthcare sector. Cardiex's products include not only the SphygmoCor Analyzer but also the Arterial Stiffness Scanner, Ambulatory Blood Pressure Monitor, CardiexCare data management system, and telehealth platform. All these products are designed to simplify and improve the monitoring and diagnosis of cardiovascular diseases. Overall, Cardiex is a successful medical technology company specializing in the development and marketing of innovative cardiovascular monitoring systems and diagnostic tools. The company has expanded its product and service offerings in recent years and has a strong international presence. Through close collaboration with other companies and research institutions, Cardiex will continue to play a leading role in the field of medical technology in the future. CardieX ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding CardieX's P/S Ratio
CardieX's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing CardieX's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating CardieX's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in CardieX’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about CardieX stock
How has the price-earnings ratio of CardieX changed compared to last year?
The price-to-earnings ratio of CardieX has increased by -80.6% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of CardieX high compared to other companies?
Yes, the price-to-earnings ratio of CardieX is high compared to other companies.
How does an increase in the price-earnings ratio of CardieX affect the company?
An increase in the price-earnings ratio of CardieX would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of CardieX affect the company?
A decrease in the price-earnings ratio of CardieX would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of CardieX?
Some factors that influence the price-earnings ratio of CardieX are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does CardieX pay?
Over the past 12 months, CardieX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CardieX is expected to pay a dividend of 0 AUD.
What is the dividend yield of CardieX?
The current dividend yield of CardieX is .
When does CardieX pay dividends?
CardieX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of CardieX?
CardieX paid dividends every year for the past 0 years.
What is the dividend of CardieX?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is CardieX located?
CardieX is assigned to the 'Health' sector.
Wann musste ich die Aktien von CardieX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CardieX from 11/8/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did CardieX pay the last dividend?
The last dividend was paid out on 11/8/2024.
What was the dividend of CardieX in the year 2023?
In the year 2023, CardieX distributed 0 AUD as dividends.
In which currency does CardieX pay out the dividend?
The dividends of CardieX are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von CardieX
Our stock analysis for CardieX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CardieX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
